NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
about
Aminoisoquinoline benzamides, FLT3 and Src-family kinase inhibitors, potently inhibit proliferation of acute myeloid leukemia cell lines.Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia.
P2860
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
NDEL1-PDGFRB fusion gene in a ...... to tyrosine kinase inhibitors.
@en
type
label
NDEL1-PDGFRB fusion gene in a ...... to tyrosine kinase inhibitors.
@en
prefLabel
NDEL1-PDGFRB fusion gene in a ...... to tyrosine kinase inhibitors.
@en
P2093
P2860
P50
P356
P1433
P1476
NDEL1-PDGFRB fusion gene in a ...... to tyrosine kinase inhibitors.
@en
P2093
C B Lucini
C M Niemeyer
K Byrgazov
M N Dworzak
M van den Heuvel-Eibrink
P2860
P2888
P304
P356
10.1038/LEU.2016.250
P577
2016-08-30T00:00:00Z
P6179
1044046773